A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.

Inhorn, R C

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity. [electronic resource] - Blood Apr 1995 - 1881-7 p. digital

Publication Type: Case Reports; Journal Article; Review

0006-4971


Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow--pathology
Bone Marrow Transplantation
Carboplatin--administration & dosage
Chromosomes, Human, Pair 13--ultrastructure
Chromosomes, Human, Pair 8--ultrastructure
Combined Modality Therapy
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Doxorubicin--administration & dosage
Eosinophilia--genetics
Etoposide--administration & dosage
Fatal Outcome
Female
Humans
Hydroxyurea--therapeutic use
Hyperplasia
Ifosfamide--administration & dosage
Leukemia, Myeloid--genetics
Lymph Nodes--pathology
Male
Middle Aged
Mitoxantrone--administration & dosage
Precursor Cell Lymphoblastic Leukemia-Lymphoma--genetics
Prednisone--administration & dosage
Pregnancy
Pregnancy Complications, Neoplastic--drug therapy
Remission Induction
Syndrome
Translocation, Genetic
Vincristine--administration & dosage